ILF2 and Miyoshi myopathy: To gain insights into the molecular mechanisms by which MM cells overcome ILF2 ASO−induced DNA damage activation, we performed bulk RNA sequencing (RNA-seq) analysis of ASO-treated KMS11 and JJN3 cells at early (1 week) and late (3 weeks) treatment time points (Supplementary Fig. 2B).